Starton Therapeutics Inc CEO Pedro Lichtinger tells Proactive the privately-held biotechnology group is appearing on a new web-based investing show named 'Unicorn Hunters' featuring a panel of judges including Apple co-founder Steve Wozniak.
Lichtinger says the group is touting its messaging of 'changing the lives of cancer patients', and will be asking investors for $20-30 million.